Literature DB >> 21501345

Control of body size in C. elegans dependent on food and insulin/IGF-1 signal.

Shuhei So1, Kohji Miyahara, Yasumi Ohshima.   

Abstract

The body size of an organism is governed by genetic and environmental factors. As an environmental factor, food appears to be the most important for body size control in animals. C. elegans worms are usually grown on an E. coli strain OP50. We show that the wild-type worms fed on another E. coli strain HB101 grow 1.6 times as large as those fed on OP50. The regression line representing the relationship between the sizes of worms grown on each food for over 30 mutants was drawn, indicating that small mutants tend to be more affected by the change in food. Mutants for the DAF-2 insulin/IGF-1 receptor and downstream SGK-1, a homolog of the serum- and glucocorticoid-inducible kinase, grow less or little larger on HB101, indicating control of body size by these factors. Results on the suppression of mutations in these factors by a mutation in the DAF-16/FOXO transcription factor indicate both DAF-16-dependent and DAF-16-independent control. Furthermore, we show that the food-dependent body size change is because of a change in cell size that is closely related to the protein content per cell.
© 2011 The Authors. Journal compilation © 2011 by the Molecular Biology Society of Japan/Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21501345     DOI: 10.1111/j.1365-2443.2011.01514.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  23 in total

1.  Novel Metrics to Characterize Embryonic Elongation of the Nematode Caenorhabditis elegans.

Authors:  Emmanuel Martin; Olivier Rocheleau-Leclair; Sarah Jenna
Journal:  J Vis Exp       Date:  2016-03-28       Impact factor: 1.355

2.  Evolutionarily conserved TRH neuropeptide pathway regulates growth in Caenorhabditis elegans.

Authors:  Elien Van Sinay; Olivier Mirabeau; Geert Depuydt; Matthias Boris Van Hiel; Katleen Peymen; Jan Watteyne; Sven Zels; Liliane Schoofs; Isabel Beets
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-01       Impact factor: 11.205

3.  APL-1, the Alzheimer's Amyloid precursor protein in Caenorhabditis elegans, modulates multiple metabolic pathways throughout development.

Authors:  Collin Y Ewald; Daniel A Raps; Chris Li
Journal:  Genetics       Date:  2012-03-30       Impact factor: 4.562

4.  Cranberry Product Decreases Fat Accumulation in Caenorhabditis elegans.

Authors:  Quancai Sun; Yiren Yue; Peiyi Shen; Jeremy J Yang; Yeonhwa Park
Journal:  J Med Food       Date:  2016-03-18       Impact factor: 2.786

5.  Characterization of the proteostasis roles of glycerol accumulation, protein degradation and protein synthesis during osmotic stress in C. elegans.

Authors:  Kristopher Burkewitz; Keith P Choe; Elaine Choung-Hee Lee; Andrew Deonarine; Kevin Strange
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

6.  Body size change in various nematodes depending on bacterial food, sex and growth temperature.

Authors:  Shuhei So; Yohei Garan; Kohji Miyahara; Yasumi Ohshima
Journal:  Worm       Date:  2012-04-01

7.  Natural Marine and Synthetic Xenobiotics Get on Nematode's Nerves: Neuro-Stimulating and Neurotoxic Findings in Caenorhabditis elegans.

Authors:  Thora Lieke; Christian E W Steinberg; Jingjuan Ju; Nadine Saul
Journal:  Mar Drugs       Date:  2015-05-06       Impact factor: 5.118

Review 8.  Use of Caenorhabditis elegans as a model to study Alzheimer's disease and other neurodegenerative diseases.

Authors:  Adanna G Alexander; Vanessa Marfil; Chris Li
Journal:  Front Genet       Date:  2014-09-05       Impact factor: 4.599

9.  A new mathematical approach for qualitative modeling of the insulin-TOR-MAPK network.

Authors:  H Frederik Nijhout; Viviane Callier
Journal:  Front Physiol       Date:  2013-09-12       Impact factor: 4.566

10.  Dietary restriction during development enlarges intestinal and hypodermal lipid droplets in Caenorhabditis elegans.

Authors:  Daniela Palgunow; Maja Klapper; Frank Döring
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.